KR
X
R&D Resources
플라즈맵 연구 기술
플라즈맵 연구 기술
R&D Resources
플라즈맵 제품들이 가지고 있는 연구 기술을 소개합니다.
Prospective Randomized Controlled Clinical Trial to Evaluate the Safety and Efficacy of ACTLINK Plasma Treatment for Promoting Osseointegration and Bone Regeneration in Dental Implants
작성자 : plasmapp(business@plasmapp.com) 작성일 : 2025-03-17 조회수 : 8
논문링크 : https://doi.org/10.3390/bioengineering11100980

Recent studies have explored surface treatments, such as increasing the hydrophilicity of implant fixtures, to enhance the osseointegration of implants. This prospective clinical study aimed to assess the clinical stability and efficacy of plasma treatment applied to implants with sandblast−acid etching (SLA) surfaces before placement. Twenty-eight patients requiring implant placement provided consent and were assigned randomly to either the SLA group without plasma treatment or the SLA/plasma group with plasma treatment. Recall checks were conducted one and three months after the first-stage surgery, followed by a second surgery at four months. Although no significant differences in buccal bone defects or implant stability were observed between the groups, the SLA/plasma group showed significant increases in marginal bone changes on the mesial and distal sides, as assessed using periapical radiographs. This study underscores the potential of pre-implantation plasma treatment to enhance bone regeneration around implants.

이전글 Impact of plasma discharge pressure on implant surface properties and osteoblast activities in vacuum-assisted plasma treatment
다음글 Efficacy of plasma treatment for surface cleansing and osseointegration of sandblasted and acid-etched titanium implants
       
제품에 대한 당신의 의견을 듣고 싶습니다.